Table 3.
Summary of the main results.
| Items | Population | |||||
|---|---|---|---|---|---|---|
| N1 | DES-ISR: pooled effect size DCB:EES (95% CI) | N2 | BMS-ISR: pooled effect size DCB:EES (95%CI) | N(N1 + N2) | Overall: pooled effect size DCB:EES (95%CI) | |
| MLD | 481 | MD = −0.25(−0.37, − 0.14)∗ | 375 | MD = −0.15(−0.39, 0.09) | 1134 | MD = −0.17(−0.29, − 0.05)∗ |
| LLL | 481 | MD = 0.04(−0.12, 0.20) | 375 | MD = −0.06(−0.35, 0.24) | 1134 | MD = −0.06(−0.23, 0.10) |
| Percent diameter stenosis | 481 | MD = 7.45(3.80, 11.09)∗ | 375 | MD = 4.69(−4.98, 14.36) | 1134 | MD = 5.37(1.33, 9.42)∗ |
| Binary restenosis | 481 | RR = 2.07(1.20, 3.58)∗ | 375 | RR = 0.89(0.47, 1.68) | 1134 | RR = 0.77(0.44, 1.34) |
| TLR | 481 | RR = 2.43(1.28, 4.62)∗ | 239 | RR = 2.23(0.70, 7.10) | 720 | RR = 2.38(1.36, 4.18)∗ |
| TVR | 481 | RR = 2.07(1.22, 3.50)∗ | 375 | RR = 0.82(0.46, 1.46) | 1134 | RR = 1.17(0.52, 2.61) |
| Myocardial infarction | 481 | RR = 1.01(0.22, 4.73) | 375 | RR = 0.80(0.31, 2.06) | 1134 | RR = 0.91(0.48, 1.73) |
| Death | 481 | RR = 1.10(0.50, 2.41) | 375 | RR = 1.45(0.62, 3.36) | 1134 | RR = 1.19(0.68, 2.07) |
DCB, drug-coated balloons; EES, everolimus-eluting stents; DES, drug-eluting stents; BMS, bare-mental stents; MLD, minimum lumen diameter; LLL, late lumen loss; TLR, target lesion revascularization; TVR, target vessel revascularization; MD, mean difference; RR, risk ratio; CI, confidence interval. ∗P < 0.05.